Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen by unknown
EPSTEIN-BARR  VIRUS-SPECIFIC  CYTOTOXIC  T 
LYMPHOCYTES  AS PROBES  OF  HLA  POLYMORPHISM 
Heterogeneity of T  Cell-restricting  Determinants Associated With the 
Serologically Defined HLA-A2 Antigen* 
BY J.  s.  H.  GASTON,* A.  B.  RICKINSON, AND M.  A.  EPSTEIN 
From the Department of Pathology, University of Bristol,  University Walk, Bristol BS8 1TD, 
United Kingdom 
Restriction of virus-specific cytotoxic T  cell function by products of the major 
histocompatability complex (MHC), 1 a  phenomenon first described in  murine 
systems  (1-3),  has  now  been  confirmed  for  the  human  T  cell  responses  to 
antigens on cells infected by influenza (4, 5), Epstein-Barr (EB) (6, 7), and more 
recently, mumps (8), measles (9), and cytomegalo- (10) 2 viruses. In each case the 
pattern of target cell iysis is consistent with a restriction through class I histocom- 
patability antigens; moreover, monoclonal antibodies to these antigens have been 
shown to protect target cells both from influenza virus- and EB virus-specific T 
cell-mediated  cytotoxicity  (11,  12).  One  important  issue  yet  to  be  resolved 
concerns the relationship between those polymorphisms of HLA antigen struc- 
ture that serve as restricting determinants for cytotoxic T  cell function and those 
polymorphisms which have for some time been defined by serological techniques, 
i.e., by "HLA-type-specific" antisera obtained from multiparous women (13). 
Studies with influenza virus-specific cytotoxic T  lymphocytes first indicated 
that  the  above  relationship,  although  close,  is  not  absolute.  Thus  HLA-A2- 
restricted effector cells prepared from several different individuals all failed to 
recognize  virus-infected  target  cells  from  a  particular  donor,  M7,  who  was 
serologically typed as positive for HLA-A2 (14), and it was shown subsequently 
that M7's HLA-A2 antigen was distinct from the "common" A2 not only in terms 
of T  cell  restriction  but  also  in  its  biochemical characteristics  as  revealed by 
isoelectric focusing (15,  16). 
Clearly human cytotoxic T  cells specific for viruses other than influenza also 
have the potential ability to distinguish variation in class I HLA antigen structure. 
Indeed, in the long run, it will be important to determine whether cytotoxic T 
cells with different viral specificities all reveal  the same pattern of HLA poly- 
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morphism or whether the pattern is itself influenced by the nature of the viral 
target  antigen.  The  present  report  describes  experiments  in  which  EB  virus- 
specific cytotoxic T  cells, prepared from HLA-A2-positive donors and expanded 
in vitro to give interleukin 2 (IL-2)-dependent T  cell lines, have been tested on 
a  large panel  of target cell lines of known  HLA type.  The results on the one 
hand show that serologically indistinguishable HLA-A2 antigens can indeed bear 
different T  cell-restricting determinants,  while on the other hand provide one 
instance in which a  serologically defined cross-reaction between otherwise quite 
distinct antigens,  HLA-A2 and HLA-Bw57, appears to be reflected in a  corre- 
sponding cross-reactivity of cytotoxic T  cell-restricting determinants. 
Materials and Methods 
Blood Donors.  60-ml blood samples were taken from healthy adult  donors by veni- 
puncture into sterile heparinised (10 U/ml) syringes, and peripheral blood mononuclear 
(PBM) cells were separated by centrifugation on Ficoli-Hypaque. The donors' immune 
status with respect to EB virus was assessed by measuring serum antibodies to the EB viral 
capsid antigen (17). 
Cell Lines.  EB virus-transformed lymphoblastoid cell lines were prepared from blood 
donors by experimental infection of T  lymphocyte-depleted PBM cells (18).  The lym- 
phoblastoid cell line from donor M7 was kindly provided by Dr. W. E. Biddison, National 
Institutes of Health,  Bethesda, MD.  In addition, certain experiments included the EB 
virus genome-negative human  leukemic cell lines HSB2 and  K562,  known to be very 
sensitive to natural killer-like cytotoxicity (19). All the cell lines were maintained by twice- 
weekly subculture in RPMI  1640 medium supplemented with 2 mM glutamine, 100 U/ 
ml penicillin, 100 #g/ml streptomycin, and 10% fetal calf serum ("culture medium"). 
HLA-typing.  Typing of donors for HLA-A, -B,  and -C,  and  HLA-DR antigens was 
carried out on PBM cells and on T-depleted PBM cells, respectively; with certain donors 
the typing was confirmed on the corresponding EB virus-transformed cell line. s These 
tests were kindly performed by Dr. B. A. Bradley and staff of the UK Transplant Service, 
South West Regional Transfusion Centre, Southmead, Bristol, UK, or in some cases by 
Dr. A. Ting and staff of the Nuffield Department of Surgery, John Radcliffe Hospital, 
Oxford, UK. 
Immunofluorescence Testing with Monoclonal Antibodies.  The monoclonal antibodies used 
were W6/32 (20), specific for a framework determinant on all HLA-A, -B, and -C antigens 
(kindly provided by Dr. W. F. Bodmer and Dr. M.J. Crumpton, Imperial Cancer Research 
Fund Laboratories, Lincoln's Inn Fields, London); MA2.1 (21), specific for a polymorphic 
determinant on  HLA-A2 and  on  HLA-B17  (Bw57/58) antigens  (kindly provided by 
Professor A. J.  McMichael, John  Radcliffe  Hospital);  and  FMC5  (22),  specific for a 
polymorphic determinant on HLA-A2 (kindly provided by Dr. H. Zola, Department of 
Clinical  Immunology, Flinders Medical Centre, Bedord Park, South Australia). Indirect 
immunofluorescence testing of lymphoblastoid cell lines for expression of HLA-A2 was 
performed exactly as  described  elsewhere  (23):  W6/32  served as  a  positive  control 
antibody and each test included a number of cell lines negative for HLA-A2 by conven- 
tional typing tests. 
Preparation of EB Virus-specific Effector T Cells.  EB virus-specific cytotoxic T cell precur- 
sors, present in the blood of immune donors, were reactivated in vitro using a modified 
version of published methods (24, 25). Briefly, 2 X 106 PBM cells were cultured with 5 x 
104 x-irradiated (4,000 rad) stimulator cells of the autologous EB virus-transformed cell 
line in 2-ml flat-bottomed wells (Linbro Chemical Co., Hamden, CT). After 10 d incuba- 
tion at 37°C, in an atmosphere of 5% CO~ in air, the cultures were harvested and the T 
cell fraction prepared by E-rosetting with sheep erythrocytes treated with 2-aminoethyli- 
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sothiouronium bromide hydrobromide. A  second in vitro stimulation was then carried 
out by culturing 5 ×  105 T  cells with 2  x  105 x-irradiated stimulator cells in 2-ml wells 
for a  further  4-6  d,  after which  5  x  105 of the  viable cells from these cultures were 
reseeded with 2 x  10 s x-irradiated stimulator cells in the presence of culture supernatants 
that contained IL-2 prepared as described elsewhere (25). Cytotoxic T cell lines established 
in this way could be maintained for many weeks by regular reseeding in IL-2 medium 
(twice weekly) with weekly additions of x-irradiated stimulator cells. 
Cytotoxicity Assays.  Effector T  cells from the IL-2-dependent T  cell lines were washed 
and resuspended in fresh IL-2-free medium for 12-18 h  before assay. Target cells and 
where necessary unlabelled "cold targets," were taken from the panel of cell lines described 
above; on certain occasions, target cells included mitogen-stimulated lymphoblasts pre- 
pared from cultures of PBM cells either 3 d after exposure to phytohemagglutinin (PHA) 
or 5 d after exposure to pokeweed mitogen (PWM). The conduct of the 5-h chromium- 
release  assay,  and  of  cold  target  competition  experiments  was  exactly  as  described 
elsewhere (26), except that the majority of assays were conducted over a range of different 
effector/target ratios (2.5:1  to 20: I). 
Monoclonal Antibody Blocking of Cytotoxicity.  Target  cells  were  pretreated  with  high 
concentrations of monoclonal antibodies W6/32 and MA2.1  (W6/32 at a final dilution 
of 1:200 and MA2.1  at a final dilution of 1:20-1:40 of purified immunoglobulin prepa- 
rations) for 20 min at 37 °C in the assay wells before addition of effector cells.  In all tests 
some target cells were similarly treated but not exposed to effector cells,  to confirm that 
the antibodies were not cytotoxic per se.  As a  further control,  high concentrations of 
monoclonal antibodies directed towards non-HLA structures on the target cell surface 
(23) were included in certain assays, and never affected the level of lysis. 
Analysis of Results of Cytotoxicity Assays.  To allow comparison of results from repeated 
testing of the same effector/target cell combination, the specific lysis was expressed on 
each occasion as a  percentage of the autologous target cell lysis observed in the  same 
experiment at the same effector/target ratio. The mean and standard deviation of the 
relative percentage lysis were then calculated for each effector/target combination.  In 
the present experiments, the absolute level of autologous target cell iysis seen in the 5-h 
chromium-release assay was usually between  35 and 55% at an effector/target ratio of 
5:1. 
Experimental Procedure.  EB virus-specific cytotoxic T  cell lines were established from 
nine virus-immune donors positive for the serologically defined HLA-A2 antigen, and the 
identity of the dominant class I HLA-restricting determinants was revealed by testing on 
a  suitable  panel  of  HLA-typed  lymphoblastoid  cell  lines.  Effector  T  cells  lines  that 
possessed demonstrable A2-restricted cytotoxicity (from four of the original nine donors) 
were selected for further study. Each was tested against a common panel of 20 EB virus- 
transformed HLA-A2-positive target cell lines, including in each case the autologous line 
as well as a majority of the available lines matched with the effector cells through HLA- 
A2 alone.  Matching through  HLA-C and -DR antigens was not considered since these 
molecules do not serve as major restricting determinants of EB virus-specific cytotoxicity 
(12, 26). 
In further experiments, lysis of autologous and of HLA-A2-matched target cells by all 
four populations of effector cells was tested in the presence and absence of high concen- 
trations of the monoclonal antibodies MA2.1 and W6/32. The specificity of one popula- 
tion of effector cells was further examined by testing on both EB virus-transformed and 
mitogen-stimulated  target  cells  from  the  same  individuals,  as  well  as  in  cold  target 
competition experiments. 
Results 
HLA-restricted Nature of EB Virus-spec~c Cytotoxic T  Cell Lines.  Fig.  1 presents 
the pattern of target cell iysis shown by the cytotoxic T  cell line established from 
EB  virus-immune  donor  BW,  the  results  having been  compiled from between 
two  and  six  separate  tests  of each  effector/target  combination  with  standard GASTON,  RICKINSON,  AND  EPSTEIN  283 
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FIGURE  1.  Cytotoxicity of an effector T  cell line from donor BW (A2, B40,  Bw44) on a 
range of target cell lines whose degree of HLA-A and -B antigen matching with the effector 
cells is as shown. The relative percentage lysis shown for each target represents the specific 
lysis of that target cell line expressed as a  percentage of the specific lysis of the autologous 
(BW) target cell line obtained in the same assay at the same effector/target cell ratio.  The 
numbers above each column denote the number of occasions on which each target was tested, 
with the standard deviations as shown. 
TABLE  I 
Dominant HLA Antigens Restricting Cytotoxicity of EB Virus-specific T Cell Lines 
Dominant HLA 
Donor  HLA type  antigens restricting 
cytotoxicity 
BW  A2  B40,w44  Cw3,w5  DR4  A2, Bw44 
KG  A2  B8,14  C-  DR3,7  A2, B8 
DG  A2,28  B8,18  C-  DR3,4  A2, B8 
EL  A2  B37,w44  CwS,w6  DR4  A2, Bw44 
deviation as shown. The figure shows only a representative range of the target 
cell lines actually tested. Although the autologous line was always perferentially 
killed, lysis of allogeneic EB virus-transformed lines could clearly be mediated 
through HLA-A2 antigen matching and to a lesser extent through Bw44 antigen 
matching. In contrast, target cells lines bearing only B40 in common with the 
effector cells were not killed above the low background level shown by HLA- 
mismatched lines.  This is a  reflection of a  more general phenomenon seen in 
this system whereby effector cell preparations from individual donors consistently 
show  preferential  restriction  through  particular  HLA-A  or  -B  antigens  (26). 
Thus,  of nine HLA-A2 EB  virus-immune donors tested in  the course of this 
work (five of whom are A2  homozygous), only four (three of whom are A2 
homozygotes) generated cytotoxic T  cell lines containing a  demonstrable A2- 
restricted component. 
Table I gives the HLA types of these four donors and indicates in each case 
the  HLA  antigens  which  were dominant restriction  elements (as  determined 
from tests upon a panel of 30-50 allogeneic virus-transformed cell lines of known 
HLA type). It is noteworthy that these effector T  cell preparations, like those 
described in earlier work (26), did not kill the EB virus-genuine-negative leukemic 
cell lines HSB2 and K562, which were included as sensitive indicators of nonspe- 
cific natural killer-like activity (data not shown). 284  EPSTEIN-BARR  VIRUS-SPECIFIC  CYTOTOXIC  T  LYMPHOCYTES 
Failure of HLA-A2-restricted  Cytotoxic T  Cells to  Lyse a  Subgroup  of A2-positive 
Targets.  Fig. 2 presents the composite results of those assays in which effector 
T  cells from donors BW,  DG, KG, and EL were each tested on the same panel 
of 20 EB virus-transformed target cell lines all bearing the serologically defined 
HLA-A2 antigen. For each effector/target combination, the level of lysis shown 
(expressed as a  percentage of the autologous cell line lysis seen with the same 
effector cells) represents the mean of between 2  and  10  separate assays.  Most 
targets in the panel shared only HLA-A2 with the effector cells, but those sharing 
other HLA-A or -B antigens are indicated on the figure; the autologous cell line 
lysis is shown by a hatched column in each case. 
It is clear that 16 of 20 HLA-A2 target cell lines were consistently lysed by all 
four effector populations at levels above 25% of autologous cell lysis. In contrast, 
there was no significant killing of three particular lines (AMc, AD, M7) by any 
of the effector cell populations, nor of one line (RT) by three of the four effector 
T  cell lines.  The discordant results obtained with these target cell lines were 
consistent in repeated testing of each of the effector cell populations and were 
confirmed when new cytotoxic T  cell preparations were made from fresh blood 
samples from two available donors (KG, DG). 
The  distinctions  between  different  cell  lines  within  the  target  cell  panel 
apparent  from Fig.  2  were clearly seen across a  range of effector/target cell 
ratios as exemplified by the results of Fig. 3. Increasing numbers of effector cells 
from donor BW showed increasingly strong lysis of five HLA-A2-matched target 
cell lines from the main panel, while lysis of the AMc,  RT,  and M7  cell lines 
remained at the very low level shown with an HLA-mismatched control target. 
Such results did not reflect an insensitivity of these particular cell lines to lysis 
by all EB virus-specific effector cells, since in parallel tests each of these lines has 
been  reproducibly  killed  by  virus~specific effector cell  populations  restricted 
through antigens other than HLA-A2. Thus RT cells are sensitive to A3- and 
B7-restricted effectors and  M7  cells are sensitive to  Bw35-restricted effectors 
(data not shown). 
Blocking of HLa-A2-restricted  Lysis by an A2-spec~c monoclonal  Antibody.  Fig. 4 
shows representative data from further experiments in which high tiler prepa- 
rations of the monoclonal antibodies MA2.1  (anti-HLA-A2) and W6/32  (anti- 
A, -B,  -C common antigen) were tested for their effect upon target cell lysis. 
These particular results were obtained using effector cells from donor DG but 
illustrate a pattern that was observed for all four effector cell preparations. Thus 
MA2.1  had  only  a  marginal  effect  upon  autologous  target  cell  lysis  when 
compared with the marked reduction of this lysis seen in the presence of W6/ 
32.  However, where the effector and target cells were matched only through 
HLA-A2 (targets EL and AH), MA2.1  blocked lysis as effectively, as did W6/ 
32.  Moreover the HLA-A2-specific monocional antibody had no effect on the 
HLA-B8-restricted  cytotoxicity present  within  this  same  effector population 
(target  LGYS).  It  was  interesting to  note that  the  low  level of killing of the 
anomalous HLA-A2-positive target cell line M7 was also unaffected by MA2.1. 
Cross-reactive L ysis of HLA-Bw5 7-positive EB Virus-transformed Cells by E  ffector Cells 
from Donor EL.  The pattern of results obtained with effector cells from donor 
EL on the panel of HLA-A2-matched target lines was essentially similar to that BW effectors 
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FIGURE 4.  Effect of monoclonal antibodies  on  the  level of lysis  of autologous,  HLA-A2 
antigen-matched and HLA-B8 antigen-matched target cell lines by effector T cells from donor 
DG (A2, A28, B8, B18).  Results are expressed as percentage specific lysis in the absence of 
antibody (hatched bar), in the presence of saturating concentrations of monoclonal antibody 
MA2.1 (open bar), or of monoclonal antibody W6/32 (dotted bar). 
shown by the other three effector cell populations except that EL effector cells 
showed consistent lysis  of the otherwise anomalous  RT cell line (Fig.  2).  It was 
therefore most important to determine whether this did indeed represent virus- 
specific HLA-A2-restricted killing.  In this regard,  it was found that lysis of RT 
cells by EL effector cells was very sensitive to the blocking effect of the mono- 
clonal antibody MA2.1  (>80% reduction); lysis of other HLA-A2-positive targets 
such as DG cells by the same effector cells was less sensitive to blocking (30-40% 
reduction) in these particular tests. Lysis of both RT and DG cells proved equally 
sensitive to blocking by W6/32  (30-40% reduction) in these same tests. GASTON,  RICKINSON,  AND  EPSTEIN  287 
This result raised the possibility that lysis of RT cells was mediated through a 
polymorphic HLA determinant closely associated with the MA2.1  binding site 
and present on the  HLA-A2,A3,B7,Bw57-positive  RT cell line.  The fact that 
MA2.1  binds not only to HLA-A2 antigens but also to a  cross-reactive epitope 
on HLA-Bw57 antigens (21) prompted a final series of experiments in which the 
testing of EL effector cells was extended to include HLA-A2-negative,  Bw57- 
positive target cell lines. 
The results, presented in Fig. 5A, clearly show the existence of a cross-reaction 
against Bw57-positive cell lines LM and TH, which, though not quite as strong 
as the well-documented reaction against A2-positive lines such as DG and KG, 
was nevertheless significant and reproducible.  In contrast,  mitogen-stimulated 
lymphoblasts from donors RT and LM (Fig.  5A) as well as from other Bw57- 
positive donors (data not shown) did not suffer significant lysis when included as 
targets  in  the  same  assays.  Finally,  in  cold  target  competition  experiments 
designed to identify the dominant antigen restricting the EL/RT effector/target 
interaction,  lysis  of the  RT cell  line was inhibited very efficiently by the A2- 
negative, Bw57-positive TH  cell  line, whereas the A2-positive,  Bw57-negative 
DG and KG cell lines competed only marginally better than two negative controls 
(Fig. 5B).  Furthermore, the HLA-A2-restricted lysis of the KG cell line by EL 
effector cells could be inhibited by another HLA-A2-positive cell line (JM) from 
the main HLA-A2 panel, while the RT cell line itself proved to be a  relatively 
poor competitor (Fig. 5 C). 
Discussion 
The evidence is now very strong that class I  HLA antigens on the surface of 
target  cells  bear  the  polymorphic restricting  determinants  that  govern  virus- 
specific cytotoxic T  cell function in man (4-10,  27). 2 However, it is not yet clear 
how closely the serologically defined polymorphisms of HLA antigen structure 
reflect the heterogeneity of T  cell-restricting determinants or how this hetero- 
geneity might itself be  influenced by the  identity of the viral antigen  against 
which the cellular response is directed. The present work describes experiments 
in the EB virus system that bear principally upon the first question but which 
could in the longer term contribute towards resolution of the second. 
The present study was  made possible through the development of methods 
whereby EB virus-specific cytotoxic T  cells, reactivated in vitro from memory 
cells in the circulation of virus-immune individuals (18), could be expanded as 
IL-2-dependent effector cell  lines  (25).  These  lines  displayed a  virus-specific, 
HLA-restricted  cytotoxicity in which the pattern of restriction of the original 
effector cell population (often involving preferential  recognition through just 
one or two of the available HLA-A and -B antigens) was faithfully maintained. 
The present studies focused on cytoxicity through HLA-A2, since experiments 
with influenza virus-specific cytotoxic T  cells had already suggested the existence 
of heterogeneity within this serologically defined antigen (14-16,  28).  Out of 
nine HLA-A2-positive EB virus-immune donors from whom effector cell lines 
were  established,  only  four  (including  three  A2  homozygotes)  generated  a 
demonstrable A2-restricted component within the polyclonal, cytotoxic response 
(Table I). Since the five donors with no detectable A2-1inked response were all t,.} 
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subsequently shown (through testing of their virus-transformed cells as targets) 
to bear the "common A2" antigen and not some unusual variant, the results in 
these cases are consistent with our earlier observations (26) suggesting that A2 
is not usually a preferred antigen for the restriction of EB virus-specific cytolysis. 
Testing of four separate HLA-A2-restricted effector cell populations on the 
same panel of 20 HLA-A2-positive EB virus-transformed target cell lines clearly 
identified a group of four lines (RT, AMc, AD, M7) whose lysis was generally 
very low. When the cells of these particular lines were serologically typed, their 
HLA antigen expression was in accord with that expected from the HLA type 
of the original donor and included expression of the serologically defined HLA- 
A2 molecule. Moreover, the four lines, as well as a  representative number of 
lines tested from within the main panel of target cells, all bound the HLA-A2/ 
B17-specific monoclonal antibody MA2.1  and the monoclonal antibody FMC5, 
whose reactivity, though less well defined, is also against an HLA-A2-associated 
determinant. The discordant results obtained with the RT, AMc, AD, and M7 
target cell  lines  in  the cytotoxicity assays in  Figs.  2  and  3  did not reflect an 
insusceptibility to EB virus-specific cytolysis per se since each line could be killed 
by virus-specific effector cells restricted through other class I HLA antigens on 
the target cell surface. The A2-restricted nature of the killing of those target cell 
lines within the main body of the panel was confirmed, in that  lysis could be 
specifically blocked by high concentrations of the MA2.1  monoclonal antibody. 
In these same tests, the much lower level of killing directed against the anomalous 
target cell lines was not at all affected by MA2.1, suggesting that none of this 
residual lysis was actually HLA-A2 restricted. 
The inference from these results must be that EB virus-specific cytolysis was 
being mediated through a polymorphic determinant (or determinants) common 
to most, but not all, serologically defined HLA-A2 molecules. It was interesting 
to note that, even within the panel of common-A2-bearing targets, each effector 
cell population  produced its  own characteristic pattern of lysis,  with  stronger 
reactivity against  some targets  than  others.  This  is  somewhat reminiscent of 
results recently obtained from an analysis of HLA-A3-restricted T  cell cytolysis 
in the influenza virus system (29) that led those workers to suggest the existence 
of multiple restriction sites on the A3 molecule. A similar inference might also 
be drawn for the common A2  molecule from the present work, but  positive 
proof of this  thesis  requires  evidence from A2-restricted T  cell clones,  each 
specific for a single restriction site. 
It will be important to determine whether the four target cell lines RT, AMc, 
AD, and M7, seroiogically typed as HLA-A2-bearing but lacking the common- 
A2-associated restricting determinant(s), all possess the same variant A2 mole- 
cule or whether each is itself distinct; the latter suggestion may be more likely 
because donors RT and AMc are Caucasian in origin,  while M7  and AD are 
Black and Asian, respectively. 
In this context, the consistent lysis of RT target cells by effector cells from 
donor EL was particularly interesting, especially as EL is homozygous for HLA- 
A2  (serologically  defined)  and  might  conceivably possess  T  cells  restricted 
through a "variant A2"-associated determinant in addition to the common-A2- 
associated reactivity dominating the other three effector cell preparations tested 290  EPSTEIN-BARR  VIRUS-SPECIFIC CYTOTOXIC  T  LYMPHOCYTES 
in this work. In fact, further analysis of the effector EL/target RT interaction 
did not substantiate this possibility but instead revealed the existence within the 
EL  effector cell  population of an  unexpected cross-reactivity directed against 
HLA-Bw57-bearing target cell lines (Fig. 5). 
This was not a cross-reactivity against an allo-determinant per se, of the kind 
that has been detected in various antigen-specific murine cytotoxic T  cell systems 
(30-32),  since only EB virus-transformed and not mitogen-stimulated (PHA or 
PWM) Bw57-bearing lymphoblasts were recognized. Thus it appeared to reflect 
a cross-reactivity at the level of HLA-restricting determinants that mediated EB 
virus-specific cytolysis. In relation to this, it is important to note that HLA-A2 
(the dominant restricting element for EL effector cell preparations) and HLA- 
Bw57 (the source of cross-reactivity) are already known to share common epitopes 
as defined by the monoclonal antibody MA2.1  (21) and by certain conventional 
HLA typing sera (33). The fact that MA2.1 blocked the effector EL/target RT 
interaction with such unusual efficiency adds weight to the view that lysis here is 
being  mediated  through  a  restricting  determinant  common to  HLA-A2  and 
Bw57 molecules. If this is the case, clearly only a  minority of the A2-restricted 
clones within the EL effector cell population recognize this particular determi- 
nant,  since  lines bearing  the common A2  antigen  such as  DG  or  KG proved 
relatively  poor  competitors of RT  cell  lysis  in  comparison  with  HLA-Bw57- 
bearing  competitor  cell  lines  (Fig.  5B).  Although  the  point  is  by  no  means 
proven,  these  findings  do  highlight  the  possibility  that  known,  serologically 
defined cross-reactions between otherwise distinct HLA antigens might in some 
cases  identify  common  epitopes  capable  of  restricting  T  cell  function.  The 
possibility is one that must now be pursued by T  cell cloning. 
Finally, the present work must be viewed in the context of parallel studies in 
the influenza virus-specific (14-16,  28),  H-Y antigen-specific (34,  35), and allo- 
specific (36,  37)  human cytotoxic T  cell systems, each of which also provides 
evidence of HLA-A2 heterogeneity. It will be important to compare the subdi- 
visions  of  HLA-A2  that  these  different  cellular  probes  reveal.  The  limited 
evidence available to date on this point is interesting in that, of the donors with 
variant  A2  expression  identified  in  this  present  study  using EB  virus-specific 
effectors, both M7 (14,  15, 34) and AMc (28,  35; referred to as AM) have also 
been  detected  as  A2  variants  using influenza  virus-specific and  H-Y  antigen- 
specific cytotoxic T  cells. It remains to be seen whether this pattern of agreement 
is maintained with more extensive analysis and indeed whether heterogeneity of 
HLA-A2 as defined by cellular probes is always reflected in altered biochemical 
properties of the A2 molecule (16). Whatever the answers to these questions, the 
work on HLA-A2 antigen heterogeneity has clearly established an experimental 
basis for the more general analysis ofpolymorphism amongst MHC gene product 
in man. 
Summary 
Epstein-Barr (EB) virus-specific effector T  cell lines were established from nine 
virus-immune donors positive for the serologically defined HLA-A2 antigen; of 
these, four lines contained a  demonstrable A2-restricted cytotoxic component. 
When these four effector populations were each tested on the same panel of EB GASTON,  RICKINSON, &ND  EPSTEIN  291 
virus-transformed lines from 20  HLA-A2-positive individuals,  16 of the target 
cell lines were consistently killed at levels above 25% of the relevant autologous 
cell iysis. Cytotoxicity appeared to be mediated through a restricting determinant 
associated with the 'common A2' antigen that these lines shared; indeed the lysis 
could  be  specifically  blocked  by  high  concentrations  of an  HLA-A2-specific 
monoclonal antibody. In contrast, 4 out of 20 target cell lines were not killed by 
HLA-A2-restricted effector cells, even though they did express the serologically 
defined A2 antigen and were found in other tests to be susceptible to EB virus- 
specific cytolysis restricted through other HLA-A or -B antigens on their surface. 
These  results suggest that EB virus-specific cytotoxic T  cells can distinguish 
between serologically identical HLA-A2 molecules via the heterogeneity of their 
T  ceil-restricting determinants.  Data from one of the effector cell populations 
further suggested that a  serologically defined cross-reaction between the other- 
wise distinct  HLA-A2 and -Bw57  antigens might also  be  reflected in a  cross- 
reactivity of T  cell-restricting determinants. 
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